Faruqi & Faruqi, LLP is Investigating STAAR Surgical Company (STAA) on Behalf of its Shareholders
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at STAAR Surgical Company (“STAAR Surgical” or the “Company”) (NasdaqGM: STAA).
The investigation focuses on whether the Company and its officers breached their fiduciary duties by causing or allowing STAAR Surgical to engage in regulatory violations at its facility.
On May 21, 2014, STAAR Surgical received a warning letter from the Food and Drug Administration (“FDA”) citing violations observed at the Company’s lens factory in Monrovia, California during an inspection. It was determined that the Company’s procedures had failed to meet the FDA’s manufacturing practice requirements.
Subsequently, in a letter dated July 3, 2014, the United States Securities and Exchange Commission (“SEC”) advised STAAR Surgical that it is conducting an inquiry into the Company’s compliance with U.S. securities laws.
If you currently own STAAR Surgical stock and have continuously owned STAAR Surgical stock since at least February 27, 2013, and would like to discuss your legal rights, please contact Stuart Guber toll free at (215) 277-5770 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding STAAR Surgical’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Please tell us about yourself by completing the form below and we will provide you with additional
information on how to join the Action.
* The submission of this form does not create an attorney-client relationship.
Stuart J. Guber
Faruqi & Faruqi, LLP
101 Greenwood Avenue Suite 600
Jenkintown, PA 19046
Tel: (215) 277-5770
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.